Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis

Abstract Background Although the presence of late gadolinium enhancement (LGE) using cardiovascular magnetic resonance imaging (CMR) is a significant discriminator of events in patients with suspected myocarditis, no data are available on the optimal LGE quantification method. Methods Six hundred se...

Full description

Bibliographic Details
Main Authors: Christoph Gräni, Christian Eichhorn, Loïc Bière, Kyoichi Kaneko, Venkatesh L. Murthy, Vikram Agarwal, Ayaz Aghayev, Michael Steigner, Ron Blankstein, Michael Jerosch-Herold, Raymond Y. Kwong
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Journal of Cardiovascular Magnetic Resonance
Subjects:
CMR
Online Access:http://link.springer.com/article/10.1186/s12968-019-0520-0
id doaj-7af8d3badbb148dd97f6da80f403cbc2
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Christoph Gräni
Christian Eichhorn
Loïc Bière
Kyoichi Kaneko
Venkatesh L. Murthy
Vikram Agarwal
Ayaz Aghayev
Michael Steigner
Ron Blankstein
Michael Jerosch-Herold
Raymond Y. Kwong
spellingShingle Christoph Gräni
Christian Eichhorn
Loïc Bière
Kyoichi Kaneko
Venkatesh L. Murthy
Vikram Agarwal
Ayaz Aghayev
Michael Steigner
Ron Blankstein
Michael Jerosch-Herold
Raymond Y. Kwong
Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
Journal of Cardiovascular Magnetic Resonance
Myocarditis
Outcome
MACE
CMR
Cardiovascular magnetic resonance imaging
Quantification method
author_facet Christoph Gräni
Christian Eichhorn
Loïc Bière
Kyoichi Kaneko
Venkatesh L. Murthy
Vikram Agarwal
Ayaz Aghayev
Michael Steigner
Ron Blankstein
Michael Jerosch-Herold
Raymond Y. Kwong
author_sort Christoph Gräni
title Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
title_short Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
title_full Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
title_fullStr Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
title_full_unstemmed Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
title_sort comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditis
publisher BMC
series Journal of Cardiovascular Magnetic Resonance
issn 1532-429X
publishDate 2019-02-01
description Abstract Background Although the presence of late gadolinium enhancement (LGE) using cardiovascular magnetic resonance imaging (CMR) is a significant discriminator of events in patients with suspected myocarditis, no data are available on the optimal LGE quantification method. Methods Six hundred seventy consecutive patients (48 ± 16 years, 59% male) with suspected myocarditis were enrolled between 2002 and 2015. We performed LGE quantitation using seven different signal intensity thresholding methods based either on 2, 3, 4, 5, 6, 7 standard deviations (SD) above remote myocardium or full width at half maximum (FWHM). In addition, a LGE visual presence score (LGE-VPS) (LGE present/absent in each segment) was assessed. For each of these methods, the strength of association of LGE results with major adverse cardiac events (MACE) was determined. Inter-and intra-rater variability using intraclass-correlation coefficient (ICC) was performed for all methods. Results Ninety-eight (15%) patients experienced a MACE at a medium follow-up of 4.7 years. LGE quantification by FWHM, 2- and 3-SD demonstrated univariable association with MACE (hazard ratio [HR] 1.05, 95% confidence interval [CI]:1.02–1.08, p = 0.001; HR 1.02, 95%CI:1.00–1.04; p = 0.001; HR 1.02, 95%CI: 1.00–1.05, p = 0.035, respectively), whereas 4-SD through 7-SD methods did not reach significant association. LGE-VPS also demonstrated association with MACE (HR 1.09, 95%CI: 1.04–1.15, p < 0.001). In the multivariable model, FWHM, 2-SD methods, and LGE-VPS each demonstrated significant association with MACE adjusted to age, sex, BMI and LVEF (adjusted HR of 1.04, 1.02, and 1.07; p = 0.009, p = 0.035; and p = 0.005, respectively). In these, FWHM and LGE-VPS had the highest degrees of inter and intra-rater reproducibility based on their high ICC values. Conclusions FWHM is the optimal semi-automated quantification method in risk-stratifying patients with suspected myocarditis, demonstrating the strongest association with MACE and the highest technical consistency. Visual LGE scoring is a reliable alternative method and is associated with a comparable association with MACE and reproducibility in these patients. Trial registration number NCT03470571. Registered 13th March 2018. Retrospectively registered.
topic Myocarditis
Outcome
MACE
CMR
Cardiovascular magnetic resonance imaging
Quantification method
url http://link.springer.com/article/10.1186/s12968-019-0520-0
work_keys_str_mv AT christophgrani comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT christianeichhorn comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT loicbiere comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT kyoichikaneko comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT venkateshlmurthy comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT vikramagarwal comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT ayazaghayev comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT michaelsteigner comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT ronblankstein comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT michaeljeroschherold comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
AT raymondykwong comparisonofmyocardialfibrosisquantificationmethodsbycardiovascularmagneticresonanceimagingforriskstratificationofpatientswithsuspectedmyocarditis
_version_ 1725310642003378176
spelling doaj-7af8d3badbb148dd97f6da80f403cbc22020-11-25T00:35:04ZengBMCJournal of Cardiovascular Magnetic Resonance1532-429X2019-02-0121111110.1186/s12968-019-0520-0Comparison of myocardial fibrosis quantification methods by cardiovascular magnetic resonance imaging for risk stratification of patients with suspected myocarditisChristoph Gräni0Christian Eichhorn1Loïc Bière2Kyoichi Kaneko3Venkatesh L. Murthy4Vikram Agarwal5Ayaz Aghayev6Michael Steigner7Ron Blankstein8Michael Jerosch-Herold9Raymond Y. Kwong10Noninvasive Cardiovascular Imaging, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolNoninvasive Cardiovascular Imaging, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolNoninvasive Cardiovascular Imaging, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolNoninvasive Cardiovascular Imaging, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolCardiovascular Imaging, Department of Radiology, Frankel Cardiovascular Center, University of MichiganNoninvasive Cardiovascular Imaging, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolNoninvasive Cardiovascular Imaging, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolNoninvasive Cardiovascular Imaging, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolNoninvasive Cardiovascular Imaging, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolNoninvasive Cardiovascular Imaging, Department of Radiology, Brigham and Women’s Hospital, Harvard Medical SchoolNoninvasive Cardiovascular Imaging, Cardiovascular Division, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical SchoolAbstract Background Although the presence of late gadolinium enhancement (LGE) using cardiovascular magnetic resonance imaging (CMR) is a significant discriminator of events in patients with suspected myocarditis, no data are available on the optimal LGE quantification method. Methods Six hundred seventy consecutive patients (48 ± 16 years, 59% male) with suspected myocarditis were enrolled between 2002 and 2015. We performed LGE quantitation using seven different signal intensity thresholding methods based either on 2, 3, 4, 5, 6, 7 standard deviations (SD) above remote myocardium or full width at half maximum (FWHM). In addition, a LGE visual presence score (LGE-VPS) (LGE present/absent in each segment) was assessed. For each of these methods, the strength of association of LGE results with major adverse cardiac events (MACE) was determined. Inter-and intra-rater variability using intraclass-correlation coefficient (ICC) was performed for all methods. Results Ninety-eight (15%) patients experienced a MACE at a medium follow-up of 4.7 years. LGE quantification by FWHM, 2- and 3-SD demonstrated univariable association with MACE (hazard ratio [HR] 1.05, 95% confidence interval [CI]:1.02–1.08, p = 0.001; HR 1.02, 95%CI:1.00–1.04; p = 0.001; HR 1.02, 95%CI: 1.00–1.05, p = 0.035, respectively), whereas 4-SD through 7-SD methods did not reach significant association. LGE-VPS also demonstrated association with MACE (HR 1.09, 95%CI: 1.04–1.15, p < 0.001). In the multivariable model, FWHM, 2-SD methods, and LGE-VPS each demonstrated significant association with MACE adjusted to age, sex, BMI and LVEF (adjusted HR of 1.04, 1.02, and 1.07; p = 0.009, p = 0.035; and p = 0.005, respectively). In these, FWHM and LGE-VPS had the highest degrees of inter and intra-rater reproducibility based on their high ICC values. Conclusions FWHM is the optimal semi-automated quantification method in risk-stratifying patients with suspected myocarditis, demonstrating the strongest association with MACE and the highest technical consistency. Visual LGE scoring is a reliable alternative method and is associated with a comparable association with MACE and reproducibility in these patients. Trial registration number NCT03470571. Registered 13th March 2018. Retrospectively registered.http://link.springer.com/article/10.1186/s12968-019-0520-0MyocarditisOutcomeMACECMRCardiovascular magnetic resonance imagingQuantification method